首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >High-throughput selected reaction monitoring liquid chromatography-mass spectrometry determination of methylphenidate and its major metabolite, ritalinic acid, in rat plasma employing monolithic columns
【24h】

High-throughput selected reaction monitoring liquid chromatography-mass spectrometry determination of methylphenidate and its major metabolite, ritalinic acid, in rat plasma employing monolithic columns

机译:高通量选择性反应监测液相色谱-质谱法使用整体式色谱柱测定大鼠血浆中的哌醋甲酯及其主要代谢产物利他林酸

获取原文
获取原文并翻译 | 示例
           

摘要

This work presents a high-throughput selected reaction monitoring (SRM) LC-MS method for the determination of methylphenidate (MPH), a central nervous stimulant, and its de-esterified metabolite, ritalinic acid (RA) in rat plasma samples. A separation of these two compounds was achieved in 15 s by employing a 3.5-ml/min flow-rate, a porous monolithic column and a TurboIonSpray source compatible with the relatively high flow-rates. In addition, a relatively fast autosampler and a new data acquisition system resulted in a time lag of less than 17 s between consecutive injections. Overall, 768 protein-precipitated rat plasma samples (eight 96-well plates) containing both MPH and RA were analyzed within 3h and 45min. The partial method validation described in this report included an assessment of linearity, intra and inter-assay precision and accuracy, and method robustness. Deuterated internal standards for the target compounds, d_3-MPH and d_5-RA, were employed. The calibration curves ranged from 0.1 to 50 ng/ml for MPH and from 0.5 to 50 ng/ml for RA. The limit of quantification (LOQ) for MPH and RA was 0.1 and 0.5 ng/ml, respectively. For both analytes, the intra- and inter-assay precision (relative standard deviation, % C.V.) and accuracy (relative error) did not exceed 15% for the quality control samples (QCs) QC1, QC2 or QC3 (0.3, 1.5 and 40 ng/ml for MPH and 0.15, 15 and 40 ng/ml for RA) for either analyte and did not exceed 20% at the lower limit of quantitation (LOQ) level. No carry-over from the autosampler was detected. The retention times remained constant throughout the experiment. Baseline resolution of MPH and RA was consistently observed throughout the plates analyzed. The described method demonstrates the feasibility for employing monolithic HPLC columns to effect rapid bioanalytical SRM LC-Ms analysis of representative biological samples.
机译:这项工作提出了一种高通量选择反应监测(SRM)LC-MS方法,用于测定大鼠血浆样品中的中枢神经兴奋剂哌醋甲酯(MPH)及其去酯化代谢产物利他林酸(RA)。通过使用3.5 ml / min的流速,多孔整体柱和与较高流速兼容的TurboIonSpray源,可以在15 s内实现这两种化合物的分离。此外,相对快速的自动进样器和新的数据采集系统导致连续进样之间的时间间隔小于17 s。总体而言,在3h和45min内分析了768种蛋白质沉淀的大鼠血浆样品(8个96孔板),其中包含MPH和RA。本报告中描述的部分方法验证包括对线性,分析内和分析间精密度和准确性以及方法稳健性的评估。使用氘代目标化合物d_3-MPH和d_5-RA的内标。 MPH的校准曲线范围为0.1至50 ng / ml,RA的校准曲线范围为0.5至50 ng / ml。 MPH和RA的定量限(LOQ)分别为0.1和0.5 ng / ml。对于两种分析物,质量控制样品(QC)QC1,QC2或QC3(0.3、1.5和40)的批内和批间精密度(相对标准偏差,%CV)和准确性(相对误差)不超过15%两种分析物的MPH浓度为ng / ml,RA的浓度分别为0.15、15和40 ng / ml,在定量下限(LOQ)下不超过20%。未检测到来自自动进样器的残留物。在整个实验过程中,保留时间保持恒定。在整个分析的平板中始终观察到MPH和RA的基线分辨率。所描述的方法证明了采用整体式HPLC色谱柱对代表性生物样品进行快速生物分析SRM LC-MS分析的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号